CO6801756A2 - Derivas de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritimia - Google Patents

Derivas de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritimia

Info

Publication number
CO6801756A2
CO6801756A2 CO13252150A CO13252150A CO6801756A2 CO 6801756 A2 CO6801756 A2 CO 6801756A2 CO 13252150 A CO13252150 A CO 13252150A CO 13252150 A CO13252150 A CO 13252150A CO 6801756 A2 CO6801756 A2 CO 6801756A2
Authority
CO
Colombia
Prior art keywords
thieno
drifts
arrhythmia
pyrimidine
treatment
Prior art date
Application number
CO13252150A
Other languages
English (en)
Spanish (es)
Inventor
Derek Eward John
John Ford
Original Assignee
Xention Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44071904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6801756(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Xention Ltd filed Critical Xention Ltd
Publication of CO6801756A2 publication Critical patent/CO6801756A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO13252150A 2011-04-01 2013-10-24 Derivas de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritimia CO6801756A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1105659.5A GB201105659D0 (en) 2011-04-01 2011-04-01 Compounds

Publications (1)

Publication Number Publication Date
CO6801756A2 true CO6801756A2 (es) 2013-11-29

Family

ID=44071904

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13252150A CO6801756A2 (es) 2011-04-01 2013-10-24 Derivas de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritimia

Country Status (42)

Country Link
US (1) US9249155B2 (https=)
EP (1) EP2694518B1 (https=)
JP (1) JP5826374B2 (https=)
KR (1) KR20140023332A (https=)
CN (1) CN103492392B (https=)
AP (1) AP2013007198A0 (https=)
AR (1) AR088735A1 (https=)
AU (1) AU2012235882B2 (https=)
BR (1) BR112013025236A2 (https=)
CA (1) CA2831493A1 (https=)
CL (1) CL2013002789A1 (https=)
CO (1) CO6801756A2 (https=)
CR (1) CR20130488A (https=)
CU (1) CU24173B1 (https=)
CY (1) CY1117025T1 (https=)
DK (1) DK2694518T3 (https=)
EA (1) EA201301111A1 (https=)
EC (1) ECSP13012988A (https=)
ES (1) ES2558563T3 (https=)
GB (1) GB201105659D0 (https=)
GT (1) GT201300225A (https=)
HR (1) HRP20151340T1 (https=)
HU (1) HUE028438T2 (https=)
IL (1) IL228555A0 (https=)
MA (1) MA35064B1 (https=)
ME (1) ME02314B (https=)
MX (1) MX335937B (https=)
NI (1) NI201300100A (https=)
PE (1) PE20141021A1 (https=)
PH (1) PH12013501952A1 (https=)
PL (1) PL2694518T3 (https=)
PT (1) PT2694518E (https=)
RS (1) RS54458B1 (https=)
RU (1) RU2013148627A (https=)
SG (1) SG193578A1 (https=)
SI (1) SI2694518T1 (https=)
SM (1) SMT201500322B (https=)
TN (1) TN2013000377A1 (https=)
TW (1) TWI516265B (https=)
UA (1) UA110131C2 (https=)
WO (1) WO2012131379A1 (https=)
ZA (1) ZA201307085B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150307532A1 (en) * 2012-11-20 2015-10-29 The Royal Institution For The Advancement Of Learning/Mcgill University Thienopyrimidine inhibitors of farnesyl and/or geranylgeranyl pyrophosphate synthase
JP7114076B2 (ja) 2015-12-22 2022-08-08 シャイ・セラピューティクス・エルエルシー がん及び炎症性疾患の処置のための化合物
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物
JP7514005B2 (ja) * 2017-06-21 2024-07-10 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ラソパシー、及び線維性疾患の治療のためのrasスーパーファミリーと相互作用する化合物
JP7407461B2 (ja) 2018-12-19 2024-01-04 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリーと相互作用する化合物

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH317906A (de) 1953-09-16 1956-12-15 Sandoz Ag Verfahren zur Herstellung von 1-Amino-4-oxyanthrachinonsulfonsäuren
AU521790B2 (en) 1977-05-23 1982-04-29 Ici Australia Limited Process for eradication of ticks
ZA782648B (en) 1977-05-23 1979-06-27 Ici Australia Ltd The prevention,control or eradication of infestations of ixodid ticks
DD226893A1 (de) 1981-12-15 1985-09-04 Ralf Boehm Verfahren zur herstellung von arylaminosubstituierten thieno 2,3-d pyrimidinen
IL112566A (en) 1994-02-10 2000-10-31 Wyeth John & Brother Ltd Substituted quinolinones and pharmaceutical compositions containing them
IL112568A0 (en) 1994-02-10 1995-05-26 Wyeth John & Brother Ltd Substituted quinolines, their preparation and pharmaceutical compositions containing them
IL112569A (en) 1994-02-10 1999-12-22 Wyeth John & Brother Ltd Pharmaceutical compositions comprising cyclohexylamine derivatives certain such novel compounds and their preparation
IL112567A (en) 1994-02-10 2000-02-29 Wyeth John & Brother Ltd Substituted quinolines their preparation and pharmaceutical compositions containing them
ATE227726T1 (de) 1995-08-17 2002-11-15 Takeda Chemical Industries Ltd Thienopyrimidinderivate als endothelin antagonisten
NZ333870A (en) 1996-07-26 2000-08-25 Nissan Chemical Ind Ltd 4-amino substituted chroman derivatives
US6083986A (en) 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US5969017A (en) 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5935945A (en) 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
RU2116309C1 (ru) 1997-02-13 1998-07-27 Институт медицинской паразитологии и тропической медицины им.Е.И.Марциновского 4-[(бензо-2,1,3-тиадиазолил-4)амино]-5,6,7,8-тетрагидробензотиено [2,3-d]пиримидин, обладающий противогельминтной активностью при ларвальном альвеолярном эхинококкозе
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
JP2002517385A (ja) 1998-06-05 2002-06-18 イカゲン インク. カリウムチャネル阻害剤
AU5444499A (en) 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
US6194458B1 (en) 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors
DE19929076A1 (de) 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
HUP0202690A3 (en) 1999-09-17 2005-02-28 Nissan Chemical Ind Ltd Benzopyran derivative having antiarrhytmic activity
US6555574B1 (en) 1999-09-24 2003-04-29 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
DE19947457A1 (de) 1999-10-02 2001-04-05 Aventis Pharma Gmbh 2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
US6531495B1 (en) 1999-10-02 2003-03-11 Aventis Pharma Deutschland Gmbh 2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
WO2001025224A1 (en) 1999-10-05 2001-04-12 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6887870B1 (en) 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
AU781365B2 (en) 1999-12-21 2005-05-19 Icagen, Inc. Potassium channel inhibitors
EP1322619B1 (en) 2000-09-20 2008-01-23 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10059418A1 (de) 2000-11-30 2002-06-20 Aventis Pharma Gmbh Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10060807A1 (de) 2000-12-07 2002-06-20 Aventis Pharma Gmbh Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10061876A1 (de) 2000-12-12 2002-06-20 Aventis Pharma Gmbh Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10104802A1 (de) 2001-02-02 2002-08-08 Merck Patent Gmbh Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (1)
JP2004525890A (ja) 2001-02-02 2004-08-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング ピラゾロ[4,3−d]ピリミジンおよびエンドセリンレセプターアンタゴニストまたはチエノピリミジンおよびエンドセリンレセプターアンタゴニストを含む医薬製剤
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
DE10121003A1 (de) 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10121002A1 (de) 2001-04-28 2002-11-14 Aventis Pharma Gmbh Verwendung von Anthranilsäureamiden als Medikament zur Behandlung von Arrhythmien sowie sie enthaltende pharmazeutische Zubereitungen
DE10128331A1 (de) 2001-06-12 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
HUP0400362A3 (en) 2001-06-25 2007-05-29 Nissan Chemical Ind Ltd Substituted benzopyran derivetives against arrhythmia
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
PL1641803T6 (pl) 2003-06-11 2011-04-29 Xention Ltd Pochodne tienopirymidyny jako inhibitory kanału potasowego
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
ZA200600197B (en) * 2003-07-02 2007-06-27 Vertex Pharma Pyrimidines useful as modulators of voltage-gated ion channels
RU2006128580A (ru) 2004-01-06 2008-02-20 Тайсо Фармасьютикал Ко., Лтд. (Jp) Производные тиенопиримидина и тиенопиридина, замещенные циклической аминогруппой
AU2005260077A1 (en) 2004-06-29 2006-01-12 Amgen Inc. Furanopyrimidines
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
JP5173429B2 (ja) 2004-12-09 2013-04-03 ゼンション・リミテッド 化合物
WO2007084815A2 (en) 2006-01-19 2007-07-26 Janssen Pharmaceutica, N.V. Substituted thienopyrimidine kinase inhibitors
EP2043654A2 (en) 2006-06-12 2009-04-08 Vertex Pharmaceuticals, Inc. Thienopyrimidines useful as modulators of ion channels
DE102009039893B4 (de) 2009-09-03 2012-03-29 Bundesanstalt für Materialforschung und -Prüfung (BAM) Verwendung eines Brennstoffs in einem selbstunterhaltenden pulsierenden Sauerstoff-Brennstoff-Verbrennungsprozess

Also Published As

Publication number Publication date
SI2694518T1 (sl) 2016-02-29
CU24173B1 (es) 2016-04-25
CN103492392B (zh) 2015-11-25
GB201105659D0 (en) 2011-05-18
HRP20151340T1 (hr) 2016-02-26
UA110131C2 (ru) 2015-11-25
PT2694518E (pt) 2016-02-05
RU2013148627A (ru) 2015-05-10
TN2013000377A1 (en) 2015-01-20
EP2694518A1 (en) 2014-02-12
SMT201500322B (it) 2016-02-25
PL2694518T3 (pl) 2016-03-31
HUE028438T2 (en) 2017-02-28
DK2694518T3 (en) 2015-11-09
BR112013025236A2 (pt) 2019-09-24
AP2013007198A0 (en) 2013-10-31
MX335937B (es) 2016-01-04
WO2012131379A1 (en) 2012-10-04
US20140206703A1 (en) 2014-07-24
IL228555A0 (en) 2013-12-31
PE20141021A1 (es) 2014-08-30
PH12013501952A1 (en) 2018-04-11
CA2831493A1 (en) 2012-10-04
RS54458B1 (sr) 2016-06-30
CR20130488A (es) 2013-12-06
CN103492392A (zh) 2014-01-01
EA201301111A1 (ru) 2014-02-28
JP2014509637A (ja) 2014-04-21
CL2013002789A1 (es) 2014-07-18
KR20140023332A (ko) 2014-02-26
AU2012235882B2 (en) 2015-08-06
US9249155B2 (en) 2016-02-02
AR088735A1 (es) 2014-07-02
MA35064B1 (fr) 2014-04-03
CU20130124A7 (es) 2014-01-29
HK1193096A1 (zh) 2014-09-12
NI201300100A (es) 2014-01-07
ME02314B (me) 2016-06-20
AU2012235882A1 (en) 2013-05-02
MX2013011301A (es) 2014-04-16
SG193578A1 (en) 2013-10-30
GT201300225A (es) 2014-12-30
ECSP13012988A (es) 2013-12-31
JP5826374B2 (ja) 2015-12-02
TW201244720A (en) 2012-11-16
NZ615621A (en) 2015-01-30
ES2558563T3 (es) 2016-02-05
CY1117025T1 (el) 2017-04-05
HK1193806A1 (zh) 2014-10-03
ZA201307085B (en) 2015-04-29
TWI516265B (zh) 2016-01-11
EP2694518B1 (en) 2015-10-07

Similar Documents

Publication Publication Date Title
ZA201507874B (en) 2-aminopyrido[4,3-d]pyrimidin-5-one derivatives and their use as wee-1 inhibitors
SG11201400083VA (en) Substituted annellated pyrimidine and the use thereof
ZA201506570B (en) 2-phenylimidazo[1,2-a]pyrimidines as imaging agents
ZA201204871B (en) Thiazolo[5,4-d]pyrimidines and their use as agrochemicals
BR112012029437A2 (pt) derivados de pirrolo[2,3-b]pirazina-7-carboxamida e seu uso como inibidores de jak e syk
IL243092A0 (en) New triazolo[d–4,5]pyrimidine histories
CU20160077A7 (es) Acrilamidas de pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinilo y pirrolo[2,3-d]piridinilo
EP2751112A4 (en) SUBSTITUTED PYRAZOLO [3,4-D] PYRIMIDINE AND ITS USE
CO6930363A2 (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
IL240877A0 (en) History of triazolo [5,4-d] pyrimidine, their preparation and pharmaceutical preparations containing them
SG11201402197UA (en) [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2
CO6950473A2 (es) Novedosos derivados de purina y su uso en el tratamiento de enfermedades
IL231903A0 (en) 5,7-substituted-imidazo[1,2-c]pyrimidines
ZA201406323B (en) Triazolo[4,5-d]pyrimidine derivatives
ZA201403441B (en) [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid
CO6801756A2 (es) Derivas de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritimia
IL238461A0 (en) 1 hindole-3-carboxamide derivatives and their use as p2y12 inhibitors
ZA201402226B (en) 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances
CO6811852A2 (es) Uso de 2,3-dihidroimidazo[1,2-c]quinazolinas sustituidas

Legal Events

Date Code Title Description
FG Application granted